Hostname: page-component-848d4c4894-tn8tq Total loading time: 0 Render date: 2024-06-17T02:44:20.047Z Has data issue: false hasContentIssue false

Refractory pain–depression syndrome treated with tianeptine

Published online by Cambridge University Press:  16 April 2020

P.S. Muniz
Affiliation:
Palliative Care Unit, National Cancer Institute, Rio de Janeiro, Brazil
A.E. Nardi
Affiliation:
Psychiatry Institute, Federal University, Rio de Janeiro, Brazil

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Chronic pain is strongly associated with anxiety and depression symptoms in advanced cancer patients. The comorbidity of pain and depression significally dificults symptom controll and seems to create a noxious feedback mechanism in wich:chronic PAIN > DEPRESSION > more PAIN > DEPRESION. We call this feedback circle as Pain-Depression Syndrome. Mr RA, is a 68-years-old male Caucasian. At the age of 66 an advanced prostatic adenocarcinoma was diagnosed. Bone metastases were concomitantly found. A mild bone pain was treated with tenoxicam 20 mg/day. The pain became more severe. We initially treated the pain with 400 mg/day of tramadol with partial response. A decision to start morphine was discussed. The patient had no history of mental disorder andhis family had no history of mood or anxiety disorder.He was examined by a psychiatrist who diagnosed a major depressive episode (DSM-IV-TR) associated with chronic pain syndrome (Clinical Global Impression-GGI, severity = 5). He was prescribed with amitriptyline starting with 25 mg/day and increasing up to 75 mg/day, at which dose he experienced severe anticholinergic side effects and mild confusion. Then amitriptyline was thus halted, and he was prescribed with tianeptine 12.5 mg three times a day. After a 2 week period he described a remarkable improvement of pain control (7–3 on a analogue visual scale of pain), mood, anxiety and depressive symptoms were also improved (CGI severity = 2; CGI improvement = 1). At 6 months follow-up he had very mild pain complaints and no significant mood or anxiety symptoms.

Type
Poster Session 2: Depressive Disorders
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.